RT Book, Section A1 McFarlane, Kassandra A1 Chan, Sze Wah Samuel SR Print(0) ID 1193787940 T1 Combination avelumab and axitinib treatment of advanced type B3 thymoma and thymic carcinoma is promising as second-line treatment after standard therapy. T2 2 Minute Medicine YR 2015 FD 2015 PB McGraw Hill PP New York, NY SN LK accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=597624 RD 2024/03/28 AB